OnDemand WTP Pricing Research

Despite cap on pricing import of medical devices rises | Rediff.com

For items that are under price control, such as cardiac stents, imports have not slowed down.

Of the two product categories that include stents as items of import, one grew 35 per cent to Rs 1,610 crore, while another grew marginally (1 per cent) to Rs 289.7 crore.

Knee implant, another item under price control, saw imports grow 20 per cent in FY19, compared to 4 per cent growth in FY18 and a dip of 8 per cent in FY17.

Ganesh Sabat, chief executive of Surat-based Sahajanand Medical Technologies (SMT), said price control has had no impact on import of stents, and that multinational players continue to do well.

“The market for stents, as such, has grown in terms of volumes.

“Hence, Indian players barring a few have done well. There has been 10-15 per cent growth in volumes in the domestic market, primarily led by new cath labs coming up in smaller towns and cities,” Sabat explained.

Read complete article here: 

Despite cap on pricing import of medical devices rises – Rediff.com Business.

Post a Comment

WP-SpamFree by Pole Position Marketing